Therapeutics

NovaTears (Perfluorohexyloctane 100%, 3mL) is a unique preservative-free eye lubricant and tear film stabiliser in a multi-dose bottle, specifically designed...

Theratears’s unique hypotonic and electrolyte balanced formula replicates healthy tears. It is a liquid-gel formula that provides soothing, longer lasting...

The Opti-Soothe Preservative-Free Eyelid Wipes are ideal for daily gentle cleansing to assist in the removal of debris from the...

A review of 13 medicines mentioning macular degeneration in Australia found all had inappropriately referenced the disease, prompting the health...

Glaukos’ new intraocular implant iDose is on track to complete US Food and Drug Administration trials in 2022, as the...

A biopharmaceutical company that is developing cheaper anti-VEGF treatments for major global markets, including Australia, has reported positive results from...

Cequa (ciclosporin 900 microgram/mL) is a newly-approved immunosuppressant indicated to increase tear production in affected patients where prior use of...

A new study has demonstrated that a particular biomarker can be used to select which age-related macular degeneration (AMD) patients...

Australia’s ophthalmic community has welcomed the approval of Novartis’ latest therapy for neovascular age-related macular degeneration (nAMD). Advocates hope the...